"Designing Growth Strategies is in our DNA"
Figure 1: Global Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030
Figure 2: Global Vaccines Market Value Share (%), by Type, 2022 & 2030
Figure 3: Global Vaccines Market Forecast (USD billion), by Recombinant/Conjugate/Subunit, 2019-2030
Figure 4: Global Vaccines Market Forecast (USD billion), by Inactivated, 2019-2030
Figure 5: Global Vaccines Market Forecast (USD billion), by Live Attenuated, 2019-2030
Figure 6: Global Vaccines Market Forecast (USD billion), by Toxoid, 2019-2030
Figure 7: Global Vaccines Market Value Share (%), by Route of Administration, 2022 & 2030
Figure 8: Global Vaccines Market Forecast (USD billion), by Parenteral, 2019-2030
Figure 9: Global Vaccines Market Forecast (USD billion), by Oral, 2019-2030
Figure 10: Global Vaccines Market Value Share (%), by Disease Indication, 2022 & 2030
Figure 11: Global Vaccines Market Forecast (USD billion), by Viral Diseases, 2019-2030
Figure 12: Global Vaccines Market Forecast (USD billion), by Bacterial Diseases, 2019-2030
Figure 13: Global Vaccines Market Value Share (%), by Age Group, 2022 & 2030
Figure 14: Global Vaccines Market Forecast (USD billion), by Pediatric, 2019-2030
Figure 15: Global Vaccines Market Forecast (USD billion), by Adults, 2019-2030
Figure 16: Global Vaccines Market Value Share (%), by Distribution Channel, 2022 & 2030
Figure 17: Global Vaccines Market Forecast (USD billion), by Hospital & Retail Pharmacies, 2019-2030
Figure 18: Global Vaccines Market Forecast (USD billion), by Government Suppliers, 2019-2030
Figure 19: Global Vaccines Market Forecast (USD billion), by Others, 2019-2030
Figure 20: Global Vaccines Market Value (USD billion), by Region, 2022 & 2030
Figure 21: North America Vaccines Market Value (USD billion), by Type, 2022 & 2030
Figure 22: North America Vaccines Market Value Share (%), by Type, 2022
Figure 23: North America Vaccines Market Value (USD billion), by Route of Administration, 2022 & 2030
Figure 24: North America Vaccines Market Value Share (%), by Route of Administration, 2022
Figure 25: North America Vaccines Market Value (USD billion), by Disease Indication, 2022 & 2030
Figure 26: North America Vaccines Market Value Share (%), by Disease Indication, 2022
Figure 27: North America Vaccines Market Value (USD billion), by Age Group, 2022 & 2030
Figure 28: North America Vaccines Market Value Share (%), by Age Group, 2022
Figure 29: North America Vaccines Market Value (USD billion), by Distribution Channel, 2022 & 2030
Figure 30: North America Vaccines Market Value Share (%), by Distribution Channel, 2022
Figure 31: North America Vaccines Market Value (USD billion), By Country, 2022 & 2030
Figure 32: North America Vaccines Market Value Share (%), By Country, 2022
Figure 33: Europe Vaccines Market Value (USD billion), by Type, 2022 & 2030
Figure 34: Europe Vaccines Market Value Share (%), by Type, 2022
Figure 35: Europe Vaccines Market Value (USD billion), by Route of Administration, 2022 & 2030
Figure 36: Europe Vaccines Market Value Share (%), by Route of Administration, 2022
Figure 37: Europe Vaccines Market Value (USD billion), by Disease Indication, 2022 & 2030
Figure 38: Europe Vaccines Market Value Share (%), by Disease Indication, 2022
Figure 39: Europe Vaccines Market Value (USD billion), by Age Group, 2022 & 2030
Figure 40: Europe Vaccines Market Value Share (%), by Age Group, 2022
Figure 41: Europe Vaccines Market Value (USD billion), by Distribution Channel, 2022 & 2030
Figure 42: Europe Vaccines Market Value Share (%), by Distribution Channel, 2022
Figure 43: Europe Vaccines Market Value (USD billion), By Country/ Sub-region, 2022 & 2030
Figure 44: Europe Vaccines Market Value Share (%), By Country/ Sub-region, 2022
Figure 45: Asia Pacific Vaccines Market Value (USD billion), by Type, 2022 & 2030
Figure 46: Asia Pacific Vaccines Market Value Share (%), by Type, 2022
Figure 47: Asia Pacific Vaccines Market Value (USD billion), by Route of Administration, 2022 & 2030
Figure 48: Asia Pacific Vaccines Market Value Share (%), by Route of Administration, 2022
Figure 49: Asia Pacific Vaccines Market Value (USD billion), by Disease Indication, 2022 & 2030
Figure 50: Asia Pacific Vaccines Market Value Share (%), by Disease Indication, 2022
Figure 51: Asia Pacific Vaccines Market Value (USD billion), by Age Group, 2022 & 2030
Figure 52: Asia Pacific Vaccines Market Value Share (%), by Age Group, 2022
Figure 53: Asia Pacific Vaccines Market Value (USD billion), by Distribution Channel, 2022 & 2030
Figure 54: Asia Pacific Vaccines Market Value Share (%), by Distribution Channel, 2022
Figure 55: Asia Pacific Vaccines Market Value (USD billion), By Country/ Sub-region, 2022 & 2030
Figure 56: Asia Pacific Vaccines Market Value Share (%), By Country/ Sub-region, 2022
Figure 57: Latin America Vaccines Market Value (USD billion), by Type, 2022 & 2030
Figure 58: Latin America Vaccines Market Value Share (%), by Type, 2022
Figure 59: Latin America Vaccines Market Value (USD billion), by Route of Administration, 2022 & 2030
Figure 60: Latin America Vaccines Market Value Share (%), by Route of Administration, 2022
Figure 61: Latin America Vaccines Market Value (USD billion), by Disease Indication, 2022 & 2030
Figure 62: Latin America Vaccines Market Value Share (%), by Disease Indication, 2022
Figure 63: Latin America Vaccines Market Value (USD billion), by Age Group, 2022 & 2030
Figure 64: Latin America Vaccines Market Value Share (%), by Age Group, 2022
Figure 65: Latin America Vaccines Market Value (USD billion), by Distribution Channel, 2022 & 2030
Figure 66: Latin America Vaccines Market Value Share (%), by Distribution Channel, 2022
Figure 67: Latin America Vaccines Market Value (USD billion), By Country/ Sub-region, 2022 & 2030
Figure 68: Latin America Vaccines Market Value Share (%), By Country/ Sub-region, 2022
Figure 69: Middle East & Africa Vaccines Market Value (USD billion), by Type, 2022 & 2030
Figure 70: Middle East & Africa Vaccines Market Value Share (%), by Type, 2022
Figure 71: Middle East & Africa Vaccines Market Value (USD billion), by Route of Administration, 2022 & 2030
Figure 72: Middle East & Africa Vaccines Market Value Share (%), by Route of Administration, 2022
Figure 73: Middle East & Africa Vaccines Market Value (USD billion), by Disease Indication, 2022 & 2030
Figure 74: Middle East & Africa Vaccines Market Value Share (%), by Disease Indication, 2022
Figure 75: Middle East & Africa Vaccines Market Value (USD billion), by Age Group, 2022 & 2030
Figure 76: Middle East & Africa Vaccines Market Value Share (%), by Age Group, 2022
Figure 77: Middle East & Africa Vaccines Market Value (USD billion), by Distribution Channel, 2022 & 2030
Figure 78: Middle East & Africa Vaccines Market Value Share (%), by Distribution Channel, 2022
Figure 79: Middle East & Africa Vaccines Market Value (USD billion), By Country/ Sub-region, 2022 & 2030
Figure 80: Middle East & Africa Vaccines Market Value Share (%), By Country/ Sub-region, 2022
Figure 81: Global Vaccines Market Share (%), By Company, 2022
Table 1: Global Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 2: Global Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 3: Global Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 4: Global Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 5: Global Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 6: Global Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 7: Global Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 8: Global Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2030
Table 10: North America Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 11: North America Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 12: North America Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 13: North America Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 14: North America Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 15: North America Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 16: North America Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2030
Table 17: U.S. Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 18: Canada Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 19: Europe Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 20: Europe Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 21: Europe Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 22: Europe Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 23: Europe Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 24: Europe Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 25: Europe Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 26: Europe Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030
Table 27: Germany Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 28: France Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 29: U.K. Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 30: Italy Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 31: Spain Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 32: Scandinavia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 33: Rest of Europe Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 34: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 35: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 36: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 37: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 38: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 39: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 40: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 41: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030
Table 42: India Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 43: China Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 44: Japan Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 45: Australia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 46: South East Asia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 47: Rest of Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 48: Latin America Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 49: Latin America Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 50: Latin America Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 51: Latin America Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 52: Latin America Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 53: Latin America Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 54: Latin America Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 55: Latin America Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030
Table 56: Brazil Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 57: Mexico Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 58: Rest of Latin America Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 59: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 60: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030
Table 61: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2030
Table 62: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2030
Table 63: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2030
Table 64: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2030
Table 65: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030
Table 66: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030
Table 67: GCC Countries Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 68: South Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Table 69: Rest of Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2030
Related Reports